Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis

Eur Heart J. 2007 May;28(10):1186. doi: 10.1093/eurheartj/ehl395. Epub 2006 Nov 22.

Authors

Chiara Bucciarelli-Ducci¹, Didier Locca, Gerald Barbeau, Sanjay K Prasad

Affiliation

¹ Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

PMID: 17121755
DOI: 10.1093/eurheartj/ehl395

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Amyloidosis / complications
Amyloidosis / diagnosis*
Contrast Media
Female
Gadolinium DTPA
Heart Diseases / complications
Heart Diseases / diagnosis*
Humans
Hypertrophy, Left Ventricular / diagnosis
Hypertrophy, Left Ventricular / etiology
Magnetic Resonance Imaging, Cine
Pericardial Effusion / diagnosis
Pericardial Effusion / etiology
Thrombosis / complications
Thrombosis / diagnosis*

Substances

Contrast Media
Gadolinium DTPA